Front Row Advisors’s Avanos Medical AVNS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-60
| Closed | -$1.2K | – | 528 |
|
|
2024
Q2 | $1.2K | Hold |
60
| – | – | ﹤0.01% | 884 |
|
|
2024
Q1 | $1.2K | Buy |
+60
| New | +$1.2K | ﹤0.01% | 873 |
|
|
2023
Q4 | – | Sell |
-60
| Closed | -$1.21K | – | 499 |
|
|
2023
Q3 | $1.21K | Hold |
60
| – | – | ﹤0.01% | 858 |
|
|
2023
Q2 | $2K | Hold |
60
| – | – | ﹤0.01% | 794 |
|
|
2023
Q1 | $2K | Hold |
60
| – | – | ﹤0.01% | 809 |
|
|
2022
Q4 | $2K | Hold |
60
| – | – | ﹤0.01% | 774 |
|
|
2022
Q3 | $1K | Hold |
60
| – | – | ﹤0.01% | 861 |
|
|
2022
Q2 | $2K | Hold |
60
| – | – | ﹤0.01% | 800 |
|
|
2022
Q1 | $2K | Hold |
60
| – | – | ﹤0.01% | 842 |
|
|
2021
Q4 | $2K | Hold |
60
| – | – | ﹤0.01% | 866 |
|
|
2021
Q3 | $2K | Hold |
60
| – | – | ﹤0.01% | 852 |
|
|
2021
Q2 | $2K | Hold |
60
| – | – | ﹤0.01% | 855 |
|
|
2021
Q1 | $3K | Hold |
60
| – | – | ﹤0.01% | 808 |
|
|
2020
Q4 | $3K | Hold |
60
| – | – | ﹤0.01% | 768 |
|
|
2020
Q3 | $3K | Hold |
60
| – | – | ﹤0.01% | 762 |
|
|
2020
Q2 | $2K | Hold |
60
| – | – | ﹤0.01% | 820 |
|
|
2020
Q1 | $2K | Hold |
60
| – | – | ﹤0.01% | 796 |
|
|
2019
Q4 | $2K | Hold |
60
| – | – | ﹤0.01% | 770 |
|
|
2019
Q3 | $2K | Hold |
60
| – | – | ﹤0.01% | 768 |
|
|
2019
Q2 | $3K | Hold |
60
| – | – | ﹤0.01% | 708 |
|
|
2019
Q1 | $3K | Hold |
60
| – | – | ﹤0.01% | 707 |
|
|
2018
Q4 | $3K | Hold |
60
| – | – | ﹤0.01% | 650 |
|
|
2018
Q3 | $3 | Hold |
60
| – | – | ﹤0.01% | 661 |
|
|
2018
Q2 | $3 | Hold |
60
| – | – | ﹤0.01% | 728 |
|
|
2018
Q1 | $3K | Hold |
60
| – | – | ﹤0.01% | 685 |
|
|
2017
Q4 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 598 |
|